Sage wins OK for depression drug Zulresso. Up next? Major marketing challenges

19th March 2019 Uncategorised 0

Sage Therapeutics has the first-ever approval for a prescription drug for postpartum depression, thanks to the FDA’s Tuesday nod for Zulresso. But it also has a number of big challenges ahead.

More: Sage wins OK for depression drug Zulresso. Up next? Major marketing challenges
Source: fierce